Evan Lippman's most recent trade in Teva- Pharmaceutical Industries Ltd. - ADR was a trade of 148,016 Restricted Share Units done . Disclosure was reported to the exchange on May 14, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Teva Pharmaceutical Industries | Evan Lippman | EVP, Business Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2025 | 148,016 | 148,016 | - | - | Restricted Share Units | |
Teva Pharmaceutical Industries | Evan Lippman | EVP, Business Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2025 | 47,365 | 47,365 | - | - | Restricted Share Units |